Agenus (AGEN) Assets Average (2011 - 2026)
Agenus (AGEN) posted quarterly Assets Average of $206.6 million for Q1 2026, down 3.1% year-over-year from $213.2 million in Q1 2025, and down 10.3% quarter-over-quarter from $230.3 million in Q4 2025.
Agenus (AGEN) Assets Average (2011 - 2026) Analysis & Trends
Agenus' Assets Average history runs 16 years deep, the most recent figure standing at $206.6 million for Q1 2026.
- In Q1 2026, Assets Average fell 3.1% year-over-year to $206.6 million; the TTM figure through Mar 2026 stood at $206.6 million (down 3.1% YoY), while the FY2025 annual figure was $226.5 million, down 16.13% from the prior year.
- Assets Average for Q1 2026 stood at $206.6 million, down from $230.3 million in the prior quarter.
- The five-year high for Assets Average was $453.6 million in Q1 2022, with the low at $192.7 million in Q2 2025.
- The 5-year median for Assets Average is $285.2 million (2024), against an average of $316.0 million.
- The sharpest annual moves came in 2022 and 2024: Assets Average soared 110.08% in 2022, then sank 31.07% in 2024.
- Agenus' Assets Average stood at $421.3 million in 2022, then decreased by 22.93% to $324.7 million in 2023, then fell by 28.43% to $232.4 million in 2024, then retreated by 0.87% to $230.3 million in 2025, then decreased by 10.3% to $206.6 million in 2026.
- Business Quant data shows AGEN's Assets Average at $206.6 million in Q1 2026, $230.3 million in Q4 2025, and $209.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | 179.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 179.57 Mn |
| Mar 31, 2026 | 206.63 Mn |
| Dec 31, 2025 | 230.34 Mn |
| Sep 30, 2025 | 209.56 Mn |
| Jun 30, 2025 | 192.71 Mn |
| Mar 31, 2025 | 213.24 Mn |
| Dec 31, 2024 | 232.38 Mn |
| Sep 30, 2024 | 265.45 Mn |
| Jun 30, 2024 | 274.49 Mn |
| Mar 31, 2024 | 285.24 Mn |
| Dec 31, 2023 | 324.69 Mn |
| Sep 30, 2023 | 359.53 Mn |
| Jun 30, 2023 | 398.22 Mn |
| Mar 31, 2023 | 413.21 Mn |
| Dec 31, 2022 | 421.29 Mn |
| Sep 30, 2022 | 442.60 Mn |
| Jun 30, 2022 | 448.74 Mn |
| Mar 31, 2022 | 453.63 Mn |
| Dec 31, 2021 | 451.80 Mn |
| Sep 30, 2021 | 314.97 Mn |